Mymetics Corp Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | 430K 459K 36.72M | Sales 2022 | 1.03M 1.1M 87.79M | Capitalization | 8.51M 9.09M 727M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.27M -342M | Net income 2022 | -4M -4.27M -342M | EV / Sales 2021 | 177 x |
Net Debt 2021 | 67.1M 71.67M 5.73B | Net Debt 2022 | 71.68M 76.57M 6.12B | EV / Sales 2022 | 78 x |
P/E ratio 2021 |
-1.86
x | P/E ratio 2022 |
-1.77
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 30/06/09 | |
Mario Amacker
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Staehelin
BRD | Director/Board Member | 76 | 01/07/07 |
Ulrich Burkhard
BRD | Director/Board Member | 63 | 22/03/12 |
Marcel B. Rüegg
BRD | Director/Board Member | - | 15/01/23 |
1st Jan change | Capi. | |
---|---|---|
-3.00% | 102B | |
+1.76% | 96.29B | |
+2.13% | 22.18B | |
-15.48% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.25% | 16.36B | |
+4.97% | 13.97B | |
+32.48% | 12.17B |